PERSPECTA

News from every angle

← Back to headlines

Royalty Pharma and J&J Partner on $500M R&D for Autoimmune Treatment

Royalty Pharma has entered into a $500 million research and development funding collaboration with Johnson & Johnson, specifically partnering to develop new treatments for autoimmune diseases.

30 Mar, 11:45 — 30 Mar, 11:45
PostShare

Sources

Showing 1 of 2 sources
seeking-alphaMixed15d ago

Royalty Pharma in $500M R&D funding collaboration with J&J

Read full article →

Coverage Timeline

First report: seeking-alpha · 30 Mar, 11:45Full coverage: 2 · 1hWindow: 1h
Left-leaningCenterRight-leaning
seeking-alpha30 Mar, 11:45First to report

Royalty Pharma in $500M R&D funding collaboration with J&J

1h later
Reuters30 Mar, 13:14Latest update

Royalty Pharma and J&J partner to develop autoimmune treatment - Reuters

Related Stories

Zambales Province Warns Residents of Dangerous Heat Index

just now

Toxic Smoke from Navotas Landfill Fire Reaches Bulacan Villages

just now

Financial Barriers Hinder Vaccine Access in Philippines

just now

Finnish Police Seize Unclassified Drug NEP

18m ago